Background: The vasoactive-inotropic score (VIS) predicts mortality and morbidity after paediatric cardiac surgery. Here we examined whether VIS also predicted outcome in adults after cardiac surgery, and compared predictive capability between VIS and three widely used scoring systems. Methods: This single-centre retrospective cohort study included 3213 cardiac surgery patients. Maximal VIS (VIS max ) was calculated using the highest doses of vasoactive and inotropic medications administered during the first 24 h postsurgery. We established five VIS max categories: 0e5, >5e15, >15e30, >30e45, and >45 points. The predictive accuracy of VIS max was evaluated for a composite outcome, which included 30-day mortality, mediastinitis, stroke, acute kidney injury, and myocardial infarction. Results: VIS max showed good prediction accuracy for the composite outcome [area under the curve (AUC), 0.72; 95% confidence interval (CI), 0.69e0.75]. The incidence of the composite outcome was 9.6% overall and 43% in the highest VIS max group (>45). VIS max predicted 30-day mortality (AUC, 0.76; 95% CI, 0.69e0.83) and 1-yr mortality (AUC, 0.70; 95% CI, 0.65e0.74). Prediction accuracy for unfavourable outcome was significantly better with VIS max than with Acute Physiology and Chronic Health Evaluation II (P¼0.01) and Simplified Acute Physiological Score II (P¼0.048), but not with the Sequential Organ Failure Assessment score (P¼0.32). Conclusions: In adults after cardiac surgery, VIS max predicted a composite of unfavourable outcomes and predicted mortality up to 1 yr after surgery.
ICU scoring systems are useful for estimating the severity of critical illness and predicting outcomes. However, they were not developed for postoperative cardiac surgery patients, and thus do not consider surgical success or patients' responses to surgery and cardiopulmonary bypass. 1 In the ICU, mortality and morbidity risk are often estimated using scoring systems such as the Simplified Acute Physiological Score (SAPS II/III), 2, 3 Sequential Organ Failure Assessment (SOFA), and Acute Physiology and Chronic Health Evaluation II (APACHE II). 1, 4, 5 Although cardiac surgery patients were excluded during their development, these instruments have been studied for risk assessment after cardiac surgery. 1e3, 6 Specific heart surgery risk scoresdsuch as the EuroScore II, Society of Thoracic Surgeons (STS) risk score, and Parsonnet score dwere developed to estimate the risk of cardiac surgery, mainly using preoperative health data.
7e12
The vasoactive-inotropic score (VIS) is calculated as a weighted sum of all administered inotropes and vasoconstrictors, reflecting pharmacological support of the cardiovascular system. 13 Studies in paediatric populations have shown that higher VIS predicts unfavourable outcomes, including morbidity and mortality, after cardiac surgery. The maximum VIS value within 24 h after ICU admission (VIS max ) has been assessed as a good predictor of unfavourable outcomes after paediatric cardiac surgery. 13, 15 Higher VIS values have also been associated with worse outcomes in septic paediatric patients. 18 The predictive performance of the VIS in adult populations has not been assessed.
In the present retrospective cohort study, we investigated whether VIS max predicted unfavourable outcomes after cardiac surgery in an adult population. We hypothesised that VIS max would predict short-and intermediate-term morbidity and mortality. We assessed the predictive ability of VIS max compared with that of the SOFA, APACHE II, and SAPS II scores. We also determined whether patients with the highest maximal cardiovascular failure score (value 4) according to SOFA were also in the highest risk group for unfavourable outcome according to VIS max .
Methods

Study population
We performed a single-centre retrospective cohort study including all cardiac surgery patients admitted to the ICU (n¼26 beds) at Kuopio University Hospital, Kuopio, Finland, between January 2010 and July 2014. The included patients underwent coronary artery bypass grafting (CABG) surgery, valve replacement or repair, atrial septal defect or ventricular septal defect repair, surgery for intracardiac tumours, or combined CABG and valvular or ascending aortic procedures. Patients who underwent catheter-based valvular (transapical or transfemoral aortic), aortic arch, or descending aortic procedures were excluded.
This clinical study was approved by the Research Ethic Committee of the Northern Savo Hospital District (no: 131/ 2015). It was conducted in full compliance with the ethical principles of the Declaration of Helsinki, Good Clinical Practice Guidelines, and the applicable local regulatory requirements. The requirement to obtain patient consent was waived by the ethics committee because the data analysis was retrospective.
Treatment protocol
After cardiac surgery, the patients were treated in the ICU. Patients received postoperative red blood cell transfusion if haemoglobin was <80 g L
À1
, fresh frozen plasma if the international normalised ratio was >1.5, and platelets if platelet count was <50Â10 9 L À1 , or if bleeding was because of platelet dysfunction and the patient had received preoperative acetylsalicylic acid or clopidogrel. Because of the retrospective nature of the study, there was no standardised haemodynamic treatment protocol. According to our institutional protocol, inotropic medication was initiated if the cardiac index was <1.8 L m À2 min À1 or <2.0 L m À2 min À1 with simultaneous hypotension, with MAP<65 mm Hg. Dobutamine was the first-line inotropic medication, and the second-line option was to add milrinone to dobutamine. However, if the combination of dobutamine and milrinone was insufficient to increase the cardiac output and arterial pressure, then dobutamine was replaced by norepinephrine. In this study, the maximum vasoactive-inotropic score in the first 24 h after cardiac surgery was a good independent predictor for adults of morbidity and mortality up to 1 yr after their surgery. It might be useful to include the maximum vasoactiveinotropic score as well as traditional ICU risk metrics when assessing prognosis after heart surgery. in cases of low output syndrome. Low PCWP was treated with additional fluids after a physician's evaluation.
Responses to vasoactive and inotropic medications were tracked, and infusions of these medications were titrated to the lowest required dose rates to maintain adequate cardiac output and MAP.
If weaning from cardiopulmonary bypass failed with inotropes and vasopressors 15e30 min after aortic occlusion clamp removal, an intra-aortic balloon pump was placed, extracorporeal membrane oxygenator therapy was initiated, or both. Sedation was continued until the patient exhibited a normal temperature, chest tube drainage of <100 ml h À1 , SpO 2 >90%, and haemodynamic stability. Sedation was then discontinued, and the patient was weaned from mechanical ventilation. ICU discharge was at the physician's discretion. 
Data collection methods
the maximum dosing rates of vasoactive and inotropic medications (mg kg À1 min À1 or IU kg À1 min À1 ) during the first 24 h after postoperative ICU admission, which were retrieved from the ICU critical care information system with separate database queries. 13, 19 We selected VIS max cut-off values to define five groups for an adult population instead of using values of a paediatric population. 13 Radiological imaging data were collected from our hospital radiological image archiving and communication system (Sectra, PACS, Link€ oping, Sweden). CT images were interpreted by a consultant radiologist to evaluate cerebral haemorrhage or infarction, or mediastinitis.
All data were reviewed and validated by ICU doctors and research nurses, and then stored by the Finnish Intensive Care Quality Consortium. Dates of patients' deaths were acquired from the national Causes of Death Register of Statistics Finland (Official Statistics of Finland, Helsinki, Finland).
Outcome definitions
The primary outcome was a composite of unfavourable outcomes, including 30-day mortality, mediastinitis, cerebral infarction, cerebral haemorrhage, kidney injury, and myocardial infarction. Earlier studies of VIS max have similarly defined outcome. 13, 15 Secondary outcomes were the in-ICU, 30-, 90-, 180-day, and 1-yr death rates, and prolonged ICU stay.
Mediastinitis was defined as a post-surgical mediastinum infection confirmed by CT imaging up to 1 yr after surgery, consistent with the European Association of Cardio-Thoracic Surgery definition. 20 Cerebral infarction and cerebral haemorrhage were defined as new neurological deficits with new radiological evidence within 24 h after cardiac surgery. 21 Postoperative acute kidney injury was defined as newly initiated renal replacement therapy on the ICU. 22 Multiple categories comparison was executed separately for each pair of groups. Bonferroni adjustments were used to adjust the P values. VIS max classifications were determined using a c 2 automatic interaction detection decision tree.
The Hosmer-Lemeshow goodness-of-fit test was used to confirm no significant discrepancy between predicted and observed unfavourable outcomes. Good calibration was indicated by a low c 2 and a high P value >0.05. The discriminative powers of VIS max , SOFA, APACHE II, and SAPS II regarding unfavourable outcome and mortalities were assessed by the area under the curve (AUC) of receiver operating characteristics (ROC) curves, which were compared using the nonparametric DeLong method. 26 Logistic regression modelling was used to assess associations between predictive factors and the primary outcome. Multivariable Cox regression analysis was used to assess the relationship between VIS max and other candidate predictive factors and the length of ICU stay. Data are presented as odds ratios (ORs), hazard ratios, and 95% confidence intervals (CIs). Cumulative survival curves, as a function of time, were generated using the Kaplan-Meier approach, and compared by log-rank test. The c 2 test was performed to assess whether VIS max predicted unfavourable outcome among patients with the most severe cardiovascular dysfunction/failure according to the SOFA score.
Statistical analyses were performed using IBM SPSS 24.0 (SPSS Inc., Chicago, IL, USA); the DeLong method was executed in R 3.2.1 (The R Foundation for Statistical Computing, Vienna, Austria) using the pROC 1.10.0 library. A P value <0.05 was considered to indicate statistical significance.
Results
During the observation period, 3309 consecutive cardiac surgery patients were evaluated, of whom 96 were excluded. Thus, 3213 patients were included in the analyses (Fig. 1) , among whom 1930 (60%) received vasoactive or inotrope support within 24 h after ICU admission. The median VIS max was 4.0 (IQR, 0.0e14.6) overall, and 12.0 (IQR, 6.0e21.8) among patients who received vasoactive or inotropic medication. Inotrope or vasopressor medication was administered to 985 (31%) patients at arrival to the ICU, and 130 (13%) of the patients receiving vasoactive or inotropic medication met criteria for unfavourable outcome. After 24 h, 157 (16%) of the patients receiving vasoactive or inotropic medication when arriving in the ICU were still receiving these drugs, and 56 (36%) of the patients receiving vasoactive or inotropic medication after 24 h at the ICU had unfavourable outcome.
Overall, 308 patients (9.6%) had an unfavourable outcomedmost commonly a myocardial infarction (Fig. 1) . When compared with patients with favourable outcomes, patients with unfavourable outcomes were older, more often female, had more commonly undergone an emergency procedure, had higher EuroScore II, SOFA, SAPS II, and APACHE II scores, and had lower preoperative ejection fractions and longer cardiopulmonary bypass times ( Table 1 ). The majority of operations were isolated CABG. A higher proportion of valvular, combined, and other procedures were associated with unfavourable outcomes compared to isolated CABG (Table 1) .
VIS max predicted unfavourable outcome (AUC, 0.72; 95% CI, 0.69e0.75; P<0.001; Fig. 2 ). The VIS max groups were as follows: 0e5, >5e15, >15e30, >30e45, and >45 points (Supplementary  Table S1 presents the sensitivity and specificity of the VIS max at each group). VIS max had significant predictive ability for 30-day mortality, prolonged ICU stay, and myocardial infarction (Fig. 3) . It was impossible to test whether VIS max independently predicted kidney insufficiency, cerebral haemorrhage, cerebral infarct, or mediastinitis because of the low incidences (Fig. 1) .
In binary logistic regression analysis, VIS max independently predicted unfavourable outcome when the model included age, sex, emergency procedure, cardiopulmonary bypass time, and preoperative ejection fraction ( Table S1 presents the sensitivity and specificity of the VIS max at each group) was 91.0%, with a cut-off value of 0.5. The ORs for unfavourable outcome increased linearly with increasing VIS max groups ( Table 2 ).
The discrimination power of VIS max was similar to the discrimination power of SOFA; AUC value 0.71 (95% CI, 0.67e0.74; P¼0.32). VIS max had better discrimination power for unfavourable outcome than SAPS II and APACHE II (Fig. 2) . The AUC values for these scores were lower than for VIS max : APACHE II, 0.67 (95% CI, 0.63e0.70; P¼0.01); and SAPS II, 0.69 (95% CI, 0.65e0.72; P¼0.048).
Patients with the highest cardiovascular SOFA score (n¼541) had 24% probability for unfavourable outcome. However, incidence of unfavourable outcome in VIS max groups differed widely from 11% (group '>5e15', n¼78) to 41% (group '>45', n¼124) in this highest SOFA score group (P<0.05) (Supplementary Table S2 ). VIS max was able to discriminate patients with unfavourable outcome with AUC 0.68 (CI 95% 0.63e0.74, P<0.01) (Supplementary Table S2 ).
Higher VIS max predicted higher mortality rates, with the following AUC values: in-ICU, 0.87 (95% CI, 0.77e0.98); 30-day, 0.76 (95% CI, 0.69e0.83); 90-day, 0.73 (95% CI, 0.67e0.79); 180-day, 0.71 (95% CI, 0.65e0.76); and 1-yr, 0.70 (95% CI, 0.65e0.74). The first three VIS max groups (<5, >5e15, and >15e30) did not significantly differ from each other (Fig. 4) . The VIS max groups >30e45 and >45 significantly differed between each other and with the first three groups (P<0.05) (Fig. 4) . The two highest VIS max groups showed increasing all-cause mortality during the first 2 months, with a continued slow increase up to 1 yr (Fig. 4) .
VIS max predicted the length of ICU stay according to the Cox regression analysis: hazard ratios for ICU discharge in the VIS max groups were 0.82 for group '>5e15', 0.60 for group '>15e30', 0.39 for group '>30e45', and 0.37 for group '>45' with P<0.01 (Supplementary Table S3 ). The length of ICU stay increased with increasing VIS max score. The median length of ICU stay for each VIS max group was: 0.93 days (0.86e0.98) for group '0e5'; 0.95 days (0.88e1.00) for group '>5e15'; 0.99 days (0.91e1.93) for group '>15e30'; 1.92 days (0.99e3.71) for group '>30e45'; and 2.97 days (1.73e6.33) for group '>45'. There was a significant difference between groups in pair-wise comparison of the medians (P<0.05).
The length of ICU stay increased with increasing VIS max score and also in the highest cardiovascular SOFA score group. The median length of ICU stay for each VIS max was 0.95 days (0.89e0.99) for group '>5e15', 1.0 days (0.91e2.03) for group '>15e30', 1.91 days (0.99e3.88) for group '>30e45', and 2.97 days (1.72e5.94) for group '>45'. The groups '>5e15' and '>15e30' had a similar median length of stay at the ICU (P¼0.852), but there was a significant difference between all other groups in pair-wise comparison of the medians (P<0.05).
Discussion
The main finding of this retrospective cohort study was that VIS max independently predicted unfavourable outcome after cardiac surgery in an unselected adult population. Moreover, VIS max predicted prolonged length of ICU stay. VIS max also showed good prediction accuracy and discrimination capability for mortality up to 1 yr after cardiac surgery in adults.
Previous studies showed that VIS max has good predictive accuracy and discrimination capability for infant and paediatric patients after cardiac surgery. 13,15e18 Our study showed that VIS max has similar predictive accuracy and discrimination capability in an adult population after cardiac surgery. Furthermore, in this cardiac surgery population, VIS max showed better discrimination performance than the APACHE II and SAPS II scores, and similar to the SOFA score. Although VIS max performed comparably to the SOFA score, in the highest cardiovascular SOFA group, VIS max showed better discrimination capability for the composite outcome, and also predicted prolonged stay at the ICU. VIS max might be superior to traditional scoring systems in this setting for several reasons. Traditional ICU scoring systems were initially developed and validated for general ICU patients, 2 and then studied in cardiac surgery patients. 1, 3, 6 Those scoring systems measure multiple organ dysfunction in critically ill patients, and only roughly quantitate pharmacological cardiovascular system support. In the early postoperative period after cardiac surgery, patients with a poor prognosis often do not manifest dysfunction of other organs to the same extent as they have cardiac dysfunction. Traditional scoring systems might better predict morbidity and mortality in cardiac surgery patients after the initial postoperative period, when multiorgan system dysfunction or failure is more likely to manifest. Some previous studies have evaluated inotropic and vasoactive medication administration using a dichotomous approach, generating discrepant results regarding the association between the administration of these drugs and increased morbidity and mortality.
27e29
A recent meta-analysis concluded that inotropes did not increase mortality in the overall population, but a Cochrane review highlighted the low quality of evidence concerning cardiogenic shock or low cardiac output states in many included studies. 30, 31 We found that VIS max measured on the 1st postoperative day predicted mortality up to 1 yr, while most earlier studies reported only in-ICU, in-hospital, and 30-day mortality. 1, 2, 8, 32, 33 The findings of the current study showed relatively low mortality in the lowest three VIS max groups for up to 1 yr. 10, 34 Higher vasoactive and inotropic medication doses were associated with short-term and intermediate-term mortality after cardiac surgery (Fig. 4) . In the two highest VIS max groups, mortality was relatively high in the first postoperative months, and then continued to increase slowly up to 1 yr. This finding may reflect intraoperative permanent myocardial damage or organ failure, our inadequate use of mechanical support devices (e.g. intra-aortic balloon pump and extracorporeal membrane oxygenator), instead of high doses of vasoactive drugs, or both. Alternatively, it is also possible that high doses of vasoactive drugs were merely reflective of cardiovascular morbidity, and that their administration did not themselves contribute to adverse outcomes.
Strengths and limitations
One strength of this study was the retrieval of data from an established ICU database. Second, we used a method of VIS max measurement in adult heart surgery, which was previously validated in paediatric cardiac surgery. 13 ,15e17 Third, we retrieved complete 1-yr mortality data, with no drop-outs, One limitation was that this was a single-centre study; VIS max group adjustment may be required in other cardiac surgical units, which may differ regarding vasoactive and inotropic medication treatment regimens and availability of mechanical cardiovascular support devices. Second, predictive models have limitations related to prediction of infrequent events, and earlier studies show low mortality and morbidity in cardiac surgery. 10,20e22,25 The occurrence of the Survival curves for each VIS max group. VIS max predicted cumulative mortality up to 1 yr. Mortality continuously increased within each group. There was no significant difference between the 0e5, >5e15, and >15e30 groups. The >30e45 and >45 groups significantly differed from each other and from the other groups (P¼0.001). VIS max maximum vasoactive-inotropic score. composite outcome of morbidity and mortality was also infrequent in the current study (Table 1) 
Conclusions
VIS max independently predicted unfavourable outcomes after cardiac surgery in an adult population, including short-and intermediate-term morbidity and mortality. In addition, the length of ICU stay increased with increasing VIS max score. The discrimination capability of VIS max was better in this population than traditional ICU scoring systems APACHE II, SAPS II, and similar with SOFA. The five-level VIS max classification could potentially be included in ICU scoring systems for adults after cardiac surgery.
